Joshua K Meisner1, Brian H Annex2, Richard J Price3. 1. Department of Biomedical Engineering, University of Virginia, Charlottesville, Va. 2. Division of Cardiovascular Medicine, University of Virginia, Charlottesville, Va; Cardiovascular Research Center, University of Virginia, Charlottesville, Va. 3. Department of Biomedical Engineering, University of Virginia, Charlottesville, Va; Cardiovascular Research Center, University of Virginia, Charlottesville, Va. Electronic address: rprice@virginia.edu.
Abstract
OBJECTIVE: The relative contributions of arteriogenesis, angiogenesis, and ischemic muscle tissue composition toward reperfusion after arterial occlusion are largely unknown. Differential loss of bone marrow-derived cell (BMC) matrix metalloproteinase 9 (MMP9), which has been implicated in all of these processes, was used to assess the relative contributions of these processes during limb reperfusion. METHODS: We compared collateral growth (arteriogenesis), capillary growth (angiogenesis), and ischemic muscle tissue composition after femoral artery ligation in FVB/NJ mice that had been reconstituted with bone marrow from wild-type or MMP9(-/-) mice. RESULTS: Laser Doppler perfusion imaging confirmed decreased reperfusion capacity in mice with BMC-specific loss of MMP9; however, collateral arteriogenesis was not affected. Furthermore, when accounting for the fact that muscle tissue composition changes markedly with ischemia (ie, necrotic, fibroadipose, and regenerating tissue regions are present), angiogenesis was also unaffected. Instead, BMC-specific loss of MMP9 caused an increase in the proportion of necrotic and fibroadipose tissue, which showed the strongest correlation with poor perfusion recovery. Similarly, the reciprocal loss of MMP9 from non-BMCs showed similar deficits in perfusion and tissue composition without affecting arteriogenesis. CONCLUSIONS: By concurrently analyzing arteriogenesis, angiogenesis, and ischemic tissue composition, we determined that the loss of BMC-derived or non-BMC-derived MMP9 impairs necrotic and fibroadipose tissue clearance after femoral artery ligation, despite normal arteriogenic and angiogenic vascular growth. These findings imply that therapeutic revascularization strategies for treating peripheral arterial disease may benefit from additionally targeting necrotic tissue clearance or skeletal muscle regeneration, or both.
OBJECTIVE: The relative contributions of arteriogenesis, angiogenesis, and ischemic muscle tissue composition toward reperfusion after arterial occlusion are largely unknown. Differential loss of bone marrow-derived cell (BMC) matrix metalloproteinase 9 (MMP9), which has been implicated in all of these processes, was used to assess the relative contributions of these processes during limb reperfusion. METHODS: We compared collateral growth (arteriogenesis), capillary growth (angiogenesis), and ischemic muscle tissue composition after femoral artery ligation in FVB/NJ mice that had been reconstituted with bone marrow from wild-type or MMP9(-/-) mice. RESULTS: Laser Doppler perfusion imaging confirmed decreased reperfusion capacity in mice with BMC-specific loss of MMP9; however, collateral arteriogenesis was not affected. Furthermore, when accounting for the fact that muscle tissue composition changes markedly with ischemia (ie, necrotic, fibroadipose, and regenerating tissue regions are present), angiogenesis was also unaffected. Instead, BMC-specific loss of MMP9 caused an increase in the proportion of necrotic and fibroadipose tissue, which showed the strongest correlation with poor perfusion recovery. Similarly, the reciprocal loss of MMP9 from non-BMCs showed similar deficits in perfusion and tissue composition without affecting arteriogenesis. CONCLUSIONS: By concurrently analyzing arteriogenesis, angiogenesis, and ischemic tissue composition, we determined that the loss of BMC-derived or non-BMC-derived MMP9impairs necrotic and fibroadipose tissue clearance after femoral artery ligation, despite normal arteriogenic and angiogenic vascular growth. These findings imply that therapeutic revascularization strategies for treating peripheral arterial disease may benefit from additionally targeting necrotic tissue clearance or skeletal muscle regeneration, or both.
Authors: Jennifer L Robbins; W Schuyler Jones; Brian D Duscha; Jason D Allen; William E Kraus; Judith G Regensteiner; William R Hiatt; Brian H Annex Journal: J Appl Physiol (1985) Date: 2011-04-21
Authors: Bart E Muhs; George Plitas; Yara Delgado; Ioana Ianus; Jason P Shaw; Mark A Adelman; Patrick Lamparello; Peter Shamamian; Paul Gagne Journal: J Surg Res Date: 2003-05-01 Impact factor: 2.192
Authors: Brunella Cristofaro; Yu Shi; Marcella Faria; Steven Suchting; Aurelie S Leroyer; Alexandre Trindade; Antonio Duarte; Ann C Zovein; M Luisa Iruela-Arispe; Lina R Nih; Nathalie Kubis; Daniel Henrion; Laurent Loufrani; Mihail Todiras; Johanna Schleifenbaum; Maik Gollasch; Zhen W Zhuang; Michael Simons; Anne Eichmann; Ferdinand le Noble Journal: Development Date: 2013-04 Impact factor: 6.868
Authors: George Plitas; Paul J Gagne; Bart E Muhs; Ioana A Ianus; Jason P Shaw; Mira Beudjekian; Yara Delgado; Glenn Jacobowitz; Caron Rockman; Peter Shamamian Journal: J Am Coll Surg Date: 2003-05 Impact factor: 6.113
Authors: Beate Heissig; Koichi Hattori; Sergio Dias; Matthias Friedrich; Barbara Ferris; Neil R Hackett; Ronald G Crystal; Peter Besmer; David Lyden; Malcolm A S Moore; Zena Werb; Shahin Rafii Journal: Cell Date: 2002-05-31 Impact factor: 41.582
Authors: Joshua L Heuslein; Xuanyue Li; Kelsey P Murrell; Brian H Annex; Shayn M Peirce; Richard J Price Journal: Microcirculation Date: 2015-07 Impact factor: 2.628
Authors: Kristin M Poole; Devin R McCormack; Chetan A Patil; Craig L Duvall; Melissa C Skala Journal: Biomed Opt Express Date: 2014-11-03 Impact factor: 3.732
Authors: Joerg Herold; Steven Nowak; Sawa Kostin; Jan-Marcus Daniel; Alexander Francke; Saravanan Subramaniam; Ruediger C Braun-Dullaeus; Sandip M Kanse Journal: Am J Transl Res Date: 2017-06-15 Impact factor: 4.060
Authors: Joshua L Heuslein; Kelsey P Murrell; Ryan J Leiphart; Ryan A Llewellyn; Joshua K Meisner; Richard J Price Journal: Sci Rep Date: 2016-05-31 Impact factor: 4.379
Authors: Joshua L Heuslein; Catherine M Gorick; Stephanie P McDonnell; Ji Song; Brian H Annex; Richard J Price Journal: Mol Ther Nucleic Acids Date: 2018-08-08 Impact factor: 8.886
Authors: Benjamin Okyere; Kaavya Giridhar; Amanda Hazy; Miao Chen; David Keimig; Robert C Bielitz; Hehuang Xie; Jia-Qiang He; William R Huckle; Michelle H Theus Journal: PLoS One Date: 2016-07-28 Impact factor: 3.240